170 related articles for article (PubMed ID: 28388658)
1. The prognostic significance of DAPK1 in bladder cancer.
Xie JY; Chen PC; Zhang JL; Gao ZS; Neves H; Zhang SD; Wen Q; Chen WD; Kwok HF; Lin Y
PLoS One; 2017; 12(4):e0175290. PubMed ID: 28388658
[TBL] [Abstract][Full Text] [Related]
2. FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
Du X; Wang QR; Chan E; Merchant M; Liu J; French D; Ashkenazi A; Qing J
Cancer Res; 2012 Nov; 72(22):5843-55. PubMed ID: 23019225
[TBL] [Abstract][Full Text] [Related]
3. Death-Associated Protein Kinase 1 Inhibits Progression of Thyroid Cancer by Regulating Stem Cell Markers.
You MH; Lee WK; Jin M; Song DE; Cheng SY; Kim TY; Kim WB; Jeon MJ; Kim WG
Cells; 2021 Nov; 10(11):. PubMed ID: 34831219
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of long noncoding RNA FGFR3- AS1 induces cell proliferation inhibition, apoptosis and motility reduction in bladder cancer.
Liao X; Chen J; Liu Y; He A; Wu J; Cheng J; Zhang X; Lv Z; Wang F; Mei H
Cancer Biomark; 2018 Feb; 21(2):277-285. PubMed ID: 29226855
[TBL] [Abstract][Full Text] [Related]
5. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
Tian X; Xu L; Wang P
Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
[TBL] [Abstract][Full Text] [Related]
6. Gliotoxin Enhances Autophagic Cell Death via the DAPK1-TAp63 Signaling Pathway in Paclitaxel-Resistant Ovarian Cancer Cells.
Park GB; Jeong JY; Kim D
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31336860
[TBL] [Abstract][Full Text] [Related]
7. Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1.
Xuan F; Huang M; Liu W; Ding H; Yang L; Cui H
Neuro Oncol; 2016 Jun; 18(6):819-29. PubMed ID: 26582930
[TBL] [Abstract][Full Text] [Related]
8. Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.
Yang J; Liu Y; Geng Q; Wang B
Mol Biol Rep; 2024 May; 51(1):670. PubMed ID: 38787485
[TBL] [Abstract][Full Text] [Related]
9. Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy.
Cao W; Ma E; Zhou L; Yuan T; Zhang C
World J Surg Oncol; 2017 Mar; 15(1):66. PubMed ID: 28320388
[TBL] [Abstract][Full Text] [Related]
10. Role of Methylation in the Regulation of Apoptosis Genes APAF1, DAPK1, and BCL2 in Breast Cancer.
Loginov VI; Pronina IV; Burdennyi AM; Pereyaslova EA; Braga EA; Kazubskaya TP; Kushlinskii NE
Bull Exp Biol Med; 2017 Apr; 162(6):797-800. PubMed ID: 28429233
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma.
Wei DM; Liu DY; Lei DP; Jin T; Wang J; Pan XL
Acta Otolaryngol; 2015 Jan; 135(1):70-8. PubMed ID: 25496179
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer.
Liu Y; Lan L; Huang K; Wang R; Xu C; Shi Y; Wu X; Wu Z; Zhang J; Chen L; Wang L; Yu X; Zhu H; Lu B
Oncotarget; 2014 Nov; 5(22):11209-24. PubMed ID: 25526030
[TBL] [Abstract][Full Text] [Related]
13. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
14. DAPK1 as an independent prognostic marker in liver cancer.
Li L; Guo L; Wang Q; Liu X; Zeng Y; Wen Q; Zhang S; Kwok HF; Lin Y; Liu J
PeerJ; 2017; 5():e3568. PubMed ID: 28740751
[TBL] [Abstract][Full Text] [Related]
15. Death-associated protein kinase 1 promotes growth of p53-mutant cancers.
Zhao J; Zhao D; Poage GM; Mazumdar A; Zhang Y; Hill JL; Hartman ZC; Savage MI; Mills GB; Brown PH
J Clin Invest; 2015 Jul; 125(7):2707-20. PubMed ID: 26075823
[TBL] [Abstract][Full Text] [Related]
16. Prospecting for Breast Cancer Blood Biomarkers: Death-Associated Protein Kinase 1 (DAPK1) as a Potential Candidate.
Arko-Boham B; Owusu BA; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Adams AR; Gyasi RK; Adu-Aryee NA; Mahmood S
Dis Markers; 2020; 2020():6848703. PubMed ID: 32566040
[TBL] [Abstract][Full Text] [Related]
17. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
18. FGFR3 mutational status and protein expression in patients with bladder cancer in a Jordanian population.
Bodoor K; Ghabkari A; Jaradat Z; Alkhateeb A; Jaradat S; Al-Ghazo MA; Matalka I; Musleh H; Haddad Y
Cancer Epidemiol; 2010 Dec; 34(6):724-32. PubMed ID: 20542753
[TBL] [Abstract][Full Text] [Related]
19. The prognostic significance of PD-L1 in bladder cancer.
Huang Y; Zhang SD; McCrudden C; Chan KW; Lin Y; Kwok HF
Oncol Rep; 2015 Jun; 33(6):3075-84. PubMed ID: 25963805
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
